Cysteine

vimentin ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34062408 Dynamic posttranslational modifications of cytoskeletal proteins unveil hot spots under nitroxidative stress. 2021 Aug 1
2 34203497 Molecular Insight into the Regulation of Vimentin by Cysteine Modifications and Zinc Binding. 2021 Jun 28 5
3 32244501 Zinc Differentially Modulates the Assembly of Soluble and Polymerized Vimentin. 2020 Mar 31 1
4 32255262 Vimentin S-glutathionylation at Cys328 inhibits filament elongation and induces severing of mature filaments in vitro. 2020 Dec 1
5 32711378 Type III intermediate filaments as targets and effectors of electrophiles and oxidants. 2020 Sep 2
6 30658903 Vimentin disruption by lipoxidation and electrophiles: Role of the cysteine residue and filament dynamics. 2019 May 3
7 30894168 The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells. 2019 Mar 20 4
8 31199965 Insight into the cellular effects of nitrated phospholipids: Evidence for pleiotropic mechanisms of action. 2019 Nov 20 1
9 29635011 The cysteine residue of glial fibrillary acidic protein is a critical target for lipoxidation and required for efficient network organization. 2018 May 20 2
10 26031447 Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding. 2015 Jun 2 1
11 22720028 Withaferin a alters intermediate filament organization, cell shape and behavior. 2012 1
12 18957515 Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. 2008 Nov 15 1
13 16291835 Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. 2006 Jan 1
14 8776888 Characterization of disulfide crosslink formation of human vimentin at the dimer, tetramer, and intermediate filament levels. 1996 Jul-Aug 1
15 8405422 Endoproteolysis of non-CAAX-containing isoprenylated peptides. 1993 Oct 11 1